Alcidion Group Limited (ASX:ALC)
0.0980
-0.0020 (-2.00%)
Mar 4, 2026, 4:13 PM AEST
Alcidion Group Revenue
Alcidion Group had revenue of 25.47M AUD in the half year ending December 31, 2025, with 33.64% growth. This brings the company's revenue in the last twelve months to 48.62M, up 36.43% year-over-year. In the fiscal year ending June 30, 2025, Alcidion Group had annual revenue of 40.79M with 10.06% growth.
Revenue (ttm)
48.62M
Revenue Growth
+36.43%
P/S Ratio
2.76
Revenue / Employee
357.49K
Employees
136
Market Cap
134.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 40.79M | 3.73M | 10.06% |
| Jun 30, 2024 | 37.06M | -3.34M | -8.27% |
| Jun 30, 2023 | 40.40M | 6.05M | 17.60% |
| Jun 30, 2022 | 34.36M | 8.47M | 32.74% |
| Jun 30, 2021 | 25.88M | 7.27M | 39.09% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 84.06M |
| Mach7 Technologies | 33.79M |
| Beamtree Holdings | 28.90M |
| PharmX Technologies | 7.65M |
| Vitasora Health | 5.01M |
| Emyria | 2.29M |
| PainChek | 2.09M |
| Singular Health Group | 961.53K |
Alcidion Group News
- 1 year ago - Alcidion Group Ltd (ASX:ALC) H1 2025 Earnings Call Highlights: Record Sales and Strategic ... - GuruFocus